Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CMPD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 -0.0572M
March 31, 2026 -0.0559M
December 31, 2025 -0.0446M
September 30, 2025 -0.1921M
June 30, 2025 -0.0693M
March 31, 2025 0.3841M
December 31, 2024 -0.0524M
September 30, 2024 0.1953M
June 30, 2024 -0.0631M
March 31, 2024 -0.0661M
December 31, 2023 0.0634M
September 30, 2023 0.0346M
June 30, 2023 -0.7854M
March 31, 2023 -0.06M
December 31, 2022 -0.059M
September 30, 2022 -0.0614M
June 30, 2022 -0.0677M
March 31, 2022 -0.0562M
December 31, 2021 -0.0552M
September 30, 2021 -0.0543M
June 30, 2021 -0.0534M
March 31, 2021 -0.0534M
December 31, 2020 -0.0541M
September 30, 2020 0.1592M
June 30, 2020 0.2801M
Date Value
March 31, 2020 0.0699M
December 31, 2019 -0.0511M
September 30, 2019 0.2672M
June 30, 2019 -0.0152M
March 31, 2019 0.0937M
December 31, 2018 0.1172M
September 30, 2018 -0.0061M
June 30, 2018 -0.0769M
March 31, 2018 0.0654M
December 31, 2017 -0.0069M
September 30, 2017 0.0314M
June 30, 2017 -0.0046M
March 31, 2017 -0.0031M
December 31, 2016 -0.015M
September 30, 2016 -0.0239M
June 30, 2016 -0.0585M
March 31, 2016 -0.015M
December 31, 2015 -0.0178M
September 30, 2015 -0.0365M
June 30, 2015 0.0171M
March 31, 2015 -0.029M
December 31, 2014 -0.0287M
September 30, 2014 0.038M
June 30, 2014 0.07M
March 31, 2014 0.017M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Renalytix Plc --
RadNet, Inc. 240.22M
DarioHealth Corp. 0.00
Net Medical Xpress Solutions, Inc. --
Evolent Health, Inc. -10.99M